CHRISTOPHER WILLEY, MD
Radiology at 19 St, Birmingham, AL
License number
Alabama MD.28716
Category
Radiology
Type
Radiation Oncology
Address
Address
619 19Th St SOUTH, Birmingham, AL 35233
Phone
(205) 934-6600
Personal information
See more information about CHRISTOPHER WILLEY at radaris.comName
Address
Phone
800 Lake Vista Cir, Vestavia, AL 35242
9040 Howells Ferry Rd, Semmes, AL 36575
800 Lake Vista Cir, Birmingham, AL 35242
5749 Bay La Launch Ave, Orange Beach, AL 36561
3970 Ridge Dr, Semmes, AL 36575
Organization information
See more information about CHRISTOPHER WILLEY at bizstanding.comChristopher Willey MD,PHD
1824 6 St S, Birmingham, AL 35205
Industry:
Oncology, Radiology
Phone:
(205) 978-0250 (Phone)
Christopher Douglas Willey
Uab Health System - Christopher Willey MD
1824 6 St S #107, Birmingham, AL 35205
Categories:
Oncology Physicians & Surgeons, Physicians & Surgeons
Phone:
(205) 934-2760 (Phone)
Professional information
Dr. Christopher D Willey, Birmingham AL - MD (Doctor of Medicine)
Specialties:
Radiation Oncology
Age:
49
Address:
UNIVERSITY OF ALABAMA HOSPITAL
619 19Th St S, Birmingham 35233
(205) 934-9999 (Phone), (205) 975-9694 (Fax)
University Ala Mdc Ctr Rad Onc
1700 6Th Ave S SUITE 1232, Birmingham 35233
(205) 934-5670 (Phone)
Comprehensive Cancer Center
2145 Bonner Way SUITE 100, Birmingham 35243
(205) 978-0250 (Phone)
619 19Th St S, Birmingham 35233
(205) 934-9999 (Phone), (205) 975-9694 (Fax)
University Ala Mdc Ctr Rad Onc
1700 6Th Ave S SUITE 1232, Birmingham 35233
(205) 934-5670 (Phone)
Comprehensive Cancer Center
2145 Bonner Way SUITE 100, Birmingham 35243
(205) 978-0250 (Phone)
Certifications:
Radiation Oncology, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Med Univ Of Sc Coll Of Med
Graduated: 2002
Med Univ Of Sc Coll Of Med
Graduated: 2002
Assistant Professor Of Radiation Oncology At University Of Alabama At Birmingham
Position:
Assistant Professor of Radiation Oncology at University of Alabama at Birmingham
Location:
Birmingham, Alabama Area
Industry:
Hospital & Health Care
Work:
University of Alabama at Birmingham
-
Assistant Professor of Radiation Oncology
Vanderbilt University School of Medicine
2004 - 2008
-
Resident Physician
Education:
Medical University of South Carolina 1996 - 2003
MD, PhD, Medicine and Molecular and Cellular Biology Pathobiology Duke University 1992 - 1996
BSE, Biomedical Engineering
MD, PhD, Medicine and Molecular and Cellular Biology Pathobiology Duke University 1992 - 1996
BSE, Biomedical Engineering
Christopher Douglas Willey, Birmingham AL
Specialties:
Radiation Oncology, Therapeutic Radiology, Therapeutic Roentgenology
Work:
University of AL Health Service Foundation-Pediatricss
2000 6Th Ave S, Birmingham, AL 35233 The Kirklin Clinic at Acton Rd.
2145 Bonner Way, Birmingham, AL 35243 UAB Radiation Oncology
1824 6Th St S, Birmingham, AL 35205 Birmingham Va Medical Center
700 19Th St S, Birmingham, AL 35233 University of AL Health Service Foundation-Pediatricss
1802 6Th Ave S, Birmingham, AL 35249
2000 6Th Ave S, Birmingham, AL 35233 The Kirklin Clinic at Acton Rd.
2145 Bonner Way, Birmingham, AL 35243 UAB Radiation Oncology
1824 6Th St S, Birmingham, AL 35205 Birmingham Va Medical Center
700 19Th St S, Birmingham, AL 35233 University of AL Health Service Foundation-Pediatricss
1802 6Th Ave S, Birmingham, AL 35249
Education:
Medical University of South Carolina (2003)
Bmx Mediated Signal Transduction In Irradiated Vascular Endothelium
US Patent:
8129356, Mar 6, 2012
Filed:
Oct 1, 2008
Appl. No.:
12/243640
Inventors:
Dennis E. Hallahan - Nashville TN, US
Christopher D. Willey - Birmingham AL, US
Christopher D. Willey - Birmingham AL, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 31/70, C07H 21/04
US Classification:
514 44, 536 245
Abstract:
Provided are methods for modulating the proliferation of cells and tissues. In some embodiments, the methods include administering to a subject an effective amount of a modulator of a biological activity of a bone marrow X kinase (Bmx) gene product. Also provided are methods for increasing the radiosensitivity of a target cell or tissue, methods for suppressing tumor growth, methods for inhibiting tumor blood vessel growth, and compositions that include modulators of a biological activity of a bone marrow X kinase (Bmx) gene product.